Montreal hospital tests new heart scan tracer on 20,000 patients
NCT ID NCT03275584
Summary
This study is checking the safety of a radioactive tracer called N-13 ammonia used during advanced heart imaging scans. The tracer helps doctors see blood flow to the heart more clearly than older methods. Researchers will monitor 20,000 patients for any side effects after receiving the tracer during their regular heart scan appointment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for N-13 AMMONIA SAFETY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier de l'université de Montréal
RECRUITINGMontreal, Quebec, H2X 0C1, Canada
Conditions
Explore the condition pages connected to this study.